Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross‐sectional study
Diabetic Medicine Nov 27, 2020
Maddaloni E, Moretti C, Del Toro R, et al. - Given that the risk of microvascular complications varies between people with latent autoimmune diabetes in adults (LADA) and people with type 2 diabetes, researchers conducted this cross‐sectional study to examine whether the prevalence of cardiac autonomic neuropathy, a life‐threatening complication of diabetes, also varies depending on the type of diabetes. Forty-three adults with LADA, 80 with type 1 diabetes and 61 with type 2 diabetes were screened for cardiac autonomic neuropathy with recommended tests. Seventeen participants with LADA, 21 participants with type 1 diabetes and 39 participants with type 2 diabetes were diagnosed with cardiac autonomic neuropathy. This is the first research providing a comparative assessment of cardiac autonomic neuropathy among LADA, type 1 and type 2 diabetes, which indicates a lower risk of cardiac autonomic neuropathy in LADA relative to type 2 diabetes and comparable to type 1 diabetes. Differences in age, metabolic control or cardiovascular risk factors were not the reason for this difference.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries